文献速递血栓与止血

膜联蛋白A2表达降低与细胞表面纤溶受损及静脉血栓栓塞相关

Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism.
PubMed 文献 · Blood · 2021-01-01

研究比较115例VTE患者和87名健康对照,发现原因不明易栓症患者外周血单个核细胞表面tPA依赖的纤溶活性平均降低41%,A2蛋白平均降低70%、mRNA降低30%,且与抗凝治疗无关;细胞表面纤溶与血浆纤溶系统独立。

要点

  • A2蛋白降低70%、mRNA降低30%与细胞表面低纤溶相关。
  • 细胞表面tPA依赖纤溶活性平均降低41%。
  • 细胞与血浆纤溶系统相互独立,提示A2或为新型易栓因素。

核心结论

  • 膜联蛋白A2蛋白表达降低与细胞表面低纤溶及原因不明易栓症相关,可能为新型VTE风险因素。

研究设计与样本

  • 纳入115例成人VTE患者和87名健康对照,检测外周血单个核细胞A2蛋白表达与功能。

主要发现

  • 有个人及家族VTE史且已知遗传性易栓症检测阴性者,细胞表面tPA依赖纤溶活性平均降低41%。
  • 上述受试者A2蛋白平均降低70%,mRNA水平降低30%,均与抗凝治疗无关。
  • 细胞A2蛋白及细胞表面纤溶酶生成与血浆凝块溶解时间均无相关性。

关键数值与推荐

  • A2/S100A10复合物在内皮细胞表面作为纤溶酶原和tPA共受体,使纤溶酶生成增强60倍。

临床怎么用

  • 对已知遗传性易栓症阴性的VTE患者,可考虑评估细胞表面纤溶及A2表达。

局限性

  • 外周血单个核细胞仅作为内皮细胞替代,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Reduced plasma fibrinolysis has been identified as a potential risk factor for venous thromboembolism (VTE), but the role of cell surface fibrinolysis in VTE is unknown. The annexin A2/S100A10 complex serves as a coreceptor for plasminogen and tissue plasminogen activator (tPA), augmenting plasmin generation by 60-fold on the endothelial cell surface. Several studies in both mice and humans support the concept that A2 regulates fibrin homeostasis and intravascular thrombosis in vivo. Here, we examined A2 protein expression and function in 115 adult subjects with VTE and 87 healthy controls. Using peripheral blood mononuclear cells as a surrogate for endothelial cells, we found a 41% mean decrease in cell surface tPA-dependent fibrinolytic activity in subjects who had a positive personal and family history of VTE but tested negative for known inherited thrombophilias (ITs). A2 protein was reduced on average by 70% and messenger RNA levels by 30%, but neither decrease correlated with anticoagulant therapy. Neither cell A2 protein nor cell surface plasmin generation correlated with plasma-based clot lysis times, suggesting that the plasma and cell surface fibrinolytic systems operate independently of one another. These data suggest that reduced expression of annexin A2 protein is associated with cell surface hypofibrinolysis and may represent a novel risk factor for IT.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Fassel H, Chen H, Ruisi M, et al. Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism. Blood. 2021. PMID: 33512476. doi:10.1182/blood.2020008123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。